Operating income for the third quarter increased 13.6 % year over year to a third quarter record-braking result of $ 17 . 1 ...

Entera Bio Ltd. (Nasdaq: ENTX), (“Entera” or the “Company”) a leader in the development of oral peptide and protein ...

Raises $1.25 million in additional capital at over 3x the effective price per share of the June 2025 capital raiseRestructures additional $8.6 ...

Dye & Durham Limited (the “Company” or “Dye & Durham”) (TSX: DND) today announced an update to the Frequently Asked Questions ...